LifeMD, Inc. (NASDAQ:LFMD) Receives $12.00 Average PT from Analysts

LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has earned an average rating of "Buy" from the six research firms that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $12.00.

Several research analysts have weighed in on LFMD shares. HC Wainwright reissued a "buy" rating and issued a $12.00 price target on shares of LifeMD in a report on Monday, November 11th. B. Riley assumed coverage on LifeMD in a report on Friday, August 23rd. They set a "buy" rating and a $11.00 price target for the company. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $15.00 price objective on shares of LifeMD in a report on Friday, September 20th.

Hedge Funds Weigh In On LifeMD

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Quest Partners LLC bought a new position in shares of LifeMD in the second quarter worth $31,000. nVerses Capital LLC acquired a new position in shares of LifeMD in the 3rd quarter valued at approximately $46,000. Intech Investment Management LLC bought a new stake in shares of LifeMD during the 3rd quarter worth approximately $54,000. CWM LLC acquired a new stake in shares of LifeMD during the 3rd quarter worth approximately $59,000. Finally, Los Angeles Capital Management LLC bought a new position in LifeMD in the second quarter valued at approximately $88,000. 35.52% of the stock is owned by institutional investors and hedge funds.

LifeMD Price Performance

NASDAQ:LFMD opened at $6.34 on Wednesday. The company has a market cap of $274.59 million, a P/E ratio of -9.91 and a beta of 1.23. The firm's fifty day moving average price is $5.06 and its two-hundred day moving average price is $6.08. LifeMD has a one year low of $3.99 and a one year high of $12.88. The company has a debt-to-equity ratio of 10.83, a current ratio of 0.83 and a quick ratio of 0.78.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.